Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Rituximab for Gout
Recruiting1 awardPhase 1
Los Angeles, California
This trial is testing the safety and feasibility of treating a group of people with a type of gout that is difficult to control. These individuals have not responded well to oral medications and have lost their response
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service